Close Menu

NEW YORK – Heat Biologics, a Durham, North Carolina developer of therapeutic and prophylactic vaccines, said on Monday that it is collaborating with the University of Miami to develop a point-of-care diagnostic test for COVID-19.

The test is expected to require a pharyngeal throat swab to deliver diagnostic results on a paper strip in under 30 minutes. A spokesperson for Heat Biologics said in an email that the assay will use isothermal amplification technology to detect viral nucleic acids.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.